Dr. Saland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
Fl 10
New York, NY 10029Phone+1 212-241-6187Fax+1 212-426-1972
Education & Training
- Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Nephrology, 2000 - 2002
- University of Texas Southwestern Medical CenterFellowship, Nephrology, 1999 - 2000
- Children's National HospitalResidency, Pediatrics, 1995 - 1998
- University of New Mexico School of MedicineClass of 1995
Certifications & Licensure
- NJ State Medical License 2016 - 2025
- NY State Medical License 2000 - 2025
- CT State Medical License 2022 - 2024
- ME State Medical License Active through 2001
- DC State Medical License 1996 - 2000
- NM State Medical License 1999 - 2000
- TX State Medical License 1999 - 2000
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- New York Magazine: Top Doctors Castle Connolly, 2013-2018
- Top Doctors: New York Metro Area Castle Connolly, 2007-2018
Publications & Presentations
PubMed
- 4 citationsDiagnosis and management of primary hyperoxalurias: best practices.Mini Michael, Elizabeth Harvey, Dawn S Milliner, Yaacov Frishberg, David J Sas
Pediatric Nephrology. 2024-11-01 - 18 citationsRandomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1.Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, Michael J Koren, J Scott Overcash
Kidney International Reports. 2022-03-01 - 65 citationsComplex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.Conor Gruber, Jorg J.A. Calis, Sofija Buta, Gilad D. Evrony, Jerome Martin
Immunity. 2020-09-15
Press Mentions
- NKF Roundup: Latest Data on Tolvaptan, Terlipressin, and LumasiranApril 17th, 2023
- Study: Some Teens Using Dietary Supplements Could Be at Risk for Serious HarmJune 5th, 2019
Grant Support
- Dyslipidemia In Chronic Kidney DiseaseNational Center For Research Resources2007–2009
- Chronic Kidney Disease In Children StudyNational Center For Research Resources2006–2009
- Dyslipidemia In Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: